Refining Selectivity of Branched CAMPs through Modulation of Hydrophobic–Hydrophilic Balance by Incorporation of N‑Terminal ω- Amino Acid Residues Authors: Maitery Yadav, Anurag Singh, Dhaya Shankaran Panneerselvam, Rajkumar P. Thummer, Sunanda Chatterjee Published: 2026 ABSTRACT High selectivity for pathogenic strains over mammalian host cells is a fundamental prerequisite for an antimicrobial therapeutic. Hydrophobic–hydrophilic balance has been a cornerstone for modulating AMP performance. Here, we have refined the selectivity of 2BWWR-7dL by modulating the hydrophilic–hydrophobic balance through a novel concept of the introduction of N-terminal ω-amino acid residues. C3–7dL, the lead analog, exhibited improved broad-spectrum antimicrobial potency (1.5×) against several ESKAPE pathogens and antibiotic-resistant Gram-positive strains, MRSA and VRSA, with reduced hemolytic activity and cytotoxicity toward mammalian cell lines, and an improved therapeutic index over the template peptide. Additionally, C3–7dL had potent antibiofilm activity against the model strain P. aeruginosa (>95% inhibition/eradication), salt tolerance, fast killing kinetics (∼5 min), protease and serum stability, absence of resistance development for over 45 days of continuous exposure, and a membranolytic mechanism of action, making it a very prospective therapeutic. Our in-depth mechanistic investigations through various biophysical assays on the model Gram-negative bacterium P. aeruginosa established that while a high charge-density (high hydrophilicity) promoted the outer-membrane binding (through LPS interaction) and depolarization of membranes, high hydrophobicity facilitated inner-membrane permeabilization and the intracellular leakage. We also established that the hydrophobic–hydrophilic balance was critical for attaining selectivity toward microbial membranes over mammalian membranes through ITC and fluorescence experiments. C3–7dL possessed the optimum trade-off between its hydrophilicity and hydrophobicity, which accounted for its best activity and biosafety, among the designed analogs of 2BWWR-7dL. Such intricate mechanistic investigations will enable the design of effective and biosafe antimicrobial therapeutics for the future. Introduction The discovery of the first antibiotic, penicillin, by Alexander Fleming in 1928 is considered one of the most significant breakthroughs in human history. The availability of effective antibiotics has greatly benefited society, playing a pivotal role in treating infectious diseases, enabling surgical and invasive procedures, managing high-risk medical conditions, and supporting dental care. − However, many antibiotics have become less effective against a wide range of pathogens because of the growing threat of antimicrobial resistance. This issue has largely arisen from the overuse and misuse of antibiotics in both medical and nonmedical settings, including agriculture, animal husbandry, fish farming, etc. , According to reports from the World Health Organization (WHO), antimicrobial resistance is responsible for over 1 million deaths each year. Particularly concerning are the ESKAPE pathogens: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species, which are already classified as high-risk organisms. Some strains within these groups have developed resistance to multiple classes of antibiotics, including advanced ones like colistin, making them especially difficult to treat. To address the growing challenge of antimicrobial resistance, alternative therapeutic strategies beyond those of conventional antibiotics are being explored. Among these, antimicrobial peptides (AMPs) have emerged as a promising option. , AMPs are an essential component of the innate immune system and are found across a wide range of organisms, including plants, animals, insects, and even bacteria. − They are known to adopt various secondary structures like the amphipathic helix or β-sheet-like structures, while binding to microbial membranes, though many unstructured AMPs are also known. One of the most compelling advantages of AMPs over traditional antibiotics is their reduced tendency to develop antibiotic resistance. This is largely due to their distinct modes of action. Unlike antibiotics, which typically act through a single, specific mechanism, AMPs exhibit multiple mechanisms that are broadly categorized into membrane-disruptive, intracellular-targeting (DNA/RNA binding, reactive oxygen species producing, etc.), and immunomodulatory. , This diversity enables AMPs to act against a wide spectrum of pathogens, including bacteria, fungi, and viruses, and makes the development of resistance against them difficult. Studies indicate that the primary mechanism of cationic AMPs (CAMPs) involves interaction with and disruption of microbial membranes. Some CAMPs interact with key precursor molecules involved in bacterial cell wall and membrane synthesis, ultimately disrupting membrane integrity and leading to cell death. , The structural complexity of microbial membranes makes their modification difficult without compromising microbial viability, and hence the resistance development against CAMPs is less likely. CAMPs vary widely in their sequences but generally contain a combination of charged residues, particularly cationic ones, along with both hydrophobic and hydrophilic residues. − Although AMPs offer substantial advantages over conventional antibiotics, their use in clinical settings is limited. This is due to their shortcomings, such as high developmental costs, susceptibility to protease degradation, salt intolerance, systemic toxicity, and low bioavailability. − A variety of strategies and modifications are currently being employed to design synthetic antimicrobial peptides (AMPs) with improved therapeutic performance. These approaches include the incorporation of unnatural or D-amino acids, modifications such as amino acid optimization, truncation, hybridization, lipidation, PEGylation, glycosylation, dendrimerization, cyclization, stapling, etc. The primary goal of these efforts is to produce AMPs with enhanced protease stability, reduced cytotoxicity, and improved antimicrobial efficacy. As established from multiple studies, the amphipathic nature of AMPs plays a crucial role in determining both their activity and selectivity. Microbial membranes are typically negatively charged due to the presence of anionic lipids, lipopolysaccharides (LPS) in Gram-negative bacteria, and teichoic acids associated with the peptidoglycan layer in Gram-positive bacteria. , These features promote electrostatic interactions with CAMPs. The initial electrostatic interaction is followed by the van der Waals interaction between the hydrophobic residues of the peptide and the hydrophobic core of the membranes. The amphipathic structure enables these peptides to disrupt membrane stability, penetrate the lipid bilayer, and ultimately cause intracellular leakage. , Charge and hydrophobicity are pivotal in determining the selectivity of AMPs toward bacterial membranes over mammalian ones. Striking an optimal balance promotes bacterial lysis while sparing host cells. One effective strategy to modulate this property involves the attachment of an aliphatic carbon chain to the peptide terminus, e.g., in N-terminal lipidated peptides. Other strategies involve altering the side chain lengths of the constituent amino acid residues through site-specific sequence optimizations. Bacterial membranes, abundant in anionic lipids such as phosphatidylglycerol (PG), attract CAMPs through electrostatic forces. Here, moderate hydrophobicity enables the peptides to embed in the lipid bilayer’s hydrophobic core. This triggers disruptive actions, including toroidal pore formation or carpet-model disintegration, effective against both Gram-negative and Gram-positive pathogens. In contrast, mammalian membranes predominantly contain zwitterionic phospholipids (PC/PS) and cholesterol, which lack this electrostatic pull. A terminal hydrophobic anchor may limit deep insertion into these sterically hindered bilayers. Excess hydrophobicity, however, drives indiscriminate penetration, leading to hemolysis through detergent effects or peptide aggregation that ruptures eukaryotic barriers. Similarly, excess hydrophilicity, owing to very high positive charge density, also leads to indiscriminate binding to both anionic microbial membranes and zwitterionic mammalian membranes. Therefore, a fine-tuning of peptide charge (hydrophilicity) and hydrophobicity is crucial for optimizing the therapeutic index, balancing high antimicrobial potency with safety. In one of our earlier studies, we designed linear and branched dimers of a template peptide, WWR-7, through various levels of sequence optimizations for developing potent, protease-stable, and noncytotoxic small CAMP. Among the designed peptides, a branched dimer, 2BWWR-7dL, composed entirely of D-amino acids and featuring two branches, demonstrated the strongest broad-spectrum antimicrobial potency against several Gram-positive and Gram-negative ESKAPE pathogens and the fungus Candida albicans, with a geometric mean MIC of ∼7 μM. However, it also exhibited significant hemolytic and cytotoxic effects toward mammalian cells, with an HC50 value as low as 10 μM. Given its promising antimicrobial activity, we modified this peptide to improve its selectivity toward bacterial membranes while minimizing its mammalian toxicity. Considering the importance of optimal hydrophobic–hydrophilic balance in determining peptide selectivity, a series of analogs of 2BWWR-7dL were designed by the attachment of ω-amino acids of various backbone lengths (2–6) at the N-termini. All other parameters, like the charge, residue count, and amino acid composition, remained constant. This design strategy was intended to fine-tune the hydrophobicity–hydrophilicity balance to identify an optimized peptide with enhanced antimicrobial potency and improved therapeutic potential compared to the parent peptide, 2BWWR-7dL. Results and Discussion Peptide Design, Synthesis, and Characterization As outlined earlier, building on our previous work with the branched antimicrobial peptide 2BWWR-7dL ((llwwrrl)2K-NH2), this study aimed to develop novel analogs to improve the peptide’s selectivity toward mammalian cells. Since the hydrophobic–hydrophilic balance plays a crucial role in governing interactions with bacterial and mammalian membranes, a peptide library was constructed by a novel strategy of introducing ω-amino acid residues with different carbon chain lengths at the N-termini of 2BWWR-7dL, while maintaining its overall charge. This induced a varying hydrophobicity–hydrophilicity balance in the peptides. The attachment of the ω- amino acid residues at the N-termini of the template peptide was hypothesized to maintain the protease resistance in the analog peptides. The ω- amino acid residues selected were Fmoc-β-Ala-OH, Fmoc-GABA–OH, Fmoc-5-Ava–OH, Fmoc-ε-Acp–OH, and Fmoc-7-Ahp–OH, contributing C2 to C6 backbone methylenes at the N-termini of the analogs. Based on these modifications, the peptides were designated as C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL (Figure , S1). The peptides were synthesized via Fmoc-based solid-phase peptide synthesis on Rink amide resin and purified on reverse-phase semipreparative HPLC. They were characterized using MALDI-MS (Figure S2–S7), analytical HPLC (Figure S8–S13), and 600 MHz 1H NMR spectroscopy (Figure S14–S19). All the peptides were >95% pure. The designed peptides maintained a uniform overall charge; however, their hydrophobicity varied due to differences in the backbone of the ω-amino acid residues at their N-terminus. An inspection of the retention times of the peptides in analytical HPLC revealed that C2–7dL and C3–7dL were less hydrophobic than the template peptide. The retention times of the peptides increased steadily through the series, with C6–7dL having a similar retention time and thus a similar hydrophobicity as the template peptide. The Zeta potential of all the peptides was evaluated (Figure S20). While C2–7dL and C3–7dL had increased positive zeta potential compared to the template peptide, the positive zeta potential values of C4–7dL, C5–7dL, and C6–7dL lay between the template peptide and C2–7dL. The addition of two methylene groups at the N-terminus of C2–7dL brought the branches of the template CAMP closer due to favorable van der Waals interactions, thereby decreasing its effective volume and subsequently increasing the positive charge density of C2–7dL. C3–7dL manifested similar hydrophobicity to C2–7dL. However, increasing the number of backbone methylene groups in the ω- amino acid residues from 5-Ava to 7-Ahp increased the volume, which eventually decreased the positive charge density. This subsequently increased the hydrophobicity within the series of analogs, with C6–7dL regaining similar hydrophobicity to that of the template peptide. Details of the primary sequence, net charge, molecular weights, and retention times are summarized in Table . The CD spectra of the peptides 2BWWR-7dL, C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL were recorded in water (Figure S21) to probe the structure of the peptides. All the peptides adopted a random coil conformation in water, as evidenced from the positive Cotton effect peak at ∼200 nm. An additional peak was observed at ∼230 nm, which indicated stacking of the indole rings of the tryptophan residues present in the two chains of the peptides. This peak was weakest in the template peptide 2BWWR-7dL and became more prominent in the ω amino acid-containing analogs. Schematic diagram showing the peptide design and the structure of all the ω-amino acid residues used in the study. 1Sequences and Physicochemical Properties of the Designed Peptides. PeptideSequenceChargeMolecular Weight (Theoretical)g/molMolecular Weight (Observed)g/molRetention Time(min)2BWWR-7dL(llwwrrl)2K-NH2 +62193.332197.08812.51C2–7dL(β-Ala-llwwrrl)2K-NH2 +62335.412337.80511.90C3–7dL(GABA-llwwrrl)2K-NH2 +62363.442364.67311.92C4–7dL(5-Ava-llwwrrl)2K-NH2 +62391.472392.99612.03C5–7dL(ε-Acp-llwwrrl)2K-NH2 +62419.502421.17912.26C6–7dL(7-Ahp-llwwrrl)2K-NH2 +62447.532449.15312.50aCapital/small Letters Denote L/D Amino Acid Residues, Respectively Sequences and Physicochemical Properties of the Designed Peptides. Capital/small Letters Denote L/D Amino Acid Residues, Respectively Determination of Minimum Inhibitory Concentrations (MIC) of Peptides In the Absence of Salts The minimum inhibitory concentration (MIC90), defined as the concentration of peptide required to inhibit 90% of bacterial growth, was determined using a standard microbroth dilution assay. The antimicrobial activities of the peptides 2BWWR-7dL, C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL were evaluated against a range of pathogens, including the Gram-negative bacteria P. aeruginosa, K. pneumoniae, and E. coli, and the Gram-positive bacterium S. aureus. Additionally, their efficacy was assessed against two resistant Gram-positive S. aureus strains, namely methicillin-resistant S. aureus (MRSA) and vancomycin-resistant S. aureus (VRSA). All peptides exhibited strong antimicrobial activity against all the tested pathogens (Table , Figures a, S22). The geometric means of the MIC values against all the tested strains were calculated. All the analog peptides, except for C6–7dL, had improved antimicrobial activity in comparison to the template peptide (8.09 μM). Within the series of Cn analogs, the best activity was manifested by the C3–7dL (5.16 μM), which gradually diminished with the increase in the carbon chain length of the ω- amino acid residue and became the same as the template peptide in C6–7dL (8.75 μM). Minimum inhibitory concentrations (MIC) of the peptides 2BWWR-7dL, C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL against P. aeruginosa (PA), K. pneumoniae (KP), E. coli (EC), S. aureus (SA), MRSA, and VRSA: a) in the absence of salt, and b) in the presence of a physiological concentration of salt (150 mM NaCl). c) Minimum Biofilm inhibition concentration (MBIC) and Minimum Biofilm Eradication concentration (MBEC) of peptides against P. aeruginosa bacterial biofilms. Polymyxin B was used as the control. d) time-kill kinetic study of the peptides against P. aeruginosa bacterial cells for 2 h (shown in log scale). Polymyxin B was used as the control. 2Minimum Inhibitory Concentrations (MICs) of All the Designed Peptides against P. aeruginosa, E. coli, K. Pneumoniae, S. aureus, MRSA, and VRSA Were Determined from the Broth Microdilution Assay MIC (μM) P. aeruginosa E. coli K. pneumoniae S. aureus MRSA VRSA PeptidesPBPBSPBPBSPBPBSPBPBSPBPBSPBPBSMIC*MIC#2BWWR-7dL7.57.5101510155510107.5108.099.72C2–7dL337.5101015331015555.686.82C3–7dL337.57.57.510337.57.5555.165.41C4–7dL337.57.51530337.57.5555.796.50C5–7dL337.5101520331515556.507.16C6–7dL5510153030332020558.759.36Polymyxin B111111------ Vancomycin------3355>200>200 aPolymyxin B and Vancomycin are used as the positive controls for Gram-negative and Gram-positive bacteria , respectively. All the experiments were performed in triplicate. *Geometric mean in the absence of salt, #geometric mean in the presence of salt. Minimum Inhibitory Concentrations (MICs) of All the Designed Peptides against P. aeruginosa, E. coli, K. Pneumoniae, S. aureus, MRSA, and VRSA Were Determined from the Broth Microdilution Assay Polymyxin B and Vancomycin are used as the positive controls for Gram-negative and Gram-positive bacteria , respectively. All the experiments were performed in triplicate. *Geometric mean in the absence of salt, #geometric mean in the presence of salt. In the Presence of Salts Since the human body contains physiological levels of salts, an effective antimicrobial peptide must retain its activity under such conditions. The presence of salts can interfere with interactions between positively charged peptides and negatively charged bacterial membranes, potentially reducing their efficacy. Therefore, MIC determinations were performed in the presence of physiological concentrations (150 mM) of NaCl (most prominent salt in the human body). All of the designed peptides retained their antimicrobial activity under physiological salt conditions, similar to the template peptide (Table , Figure b and S23). The salt tolerance of the antimicrobial activity of the best peptide, C3–7dL, was maintained against P. aeruginosa, S. aureus, MRSA, and VRSA, whereas a slight reduction in activity was noted against K. pneumoniae, where the activity was reduced by 1.3-fold. Determination of Minimum Biofilm Inhibition Concentration (MBIC)/ Minimum Biofilm Eradication Concentration (MBEC) Some highly virulent bacteria, such as P. aeruginosa and E. coli, can form bacterial biofilms, which are stationary colonies of microbial cells. In biofilms, cells are clustered and covered by an extracellular matrix composed of proteins, lipids, and enzymes such as proteases, which act as an additional protective layer for the cells. This protective layer enables bacteria to evade antimicrobial agents, thereby reducing their effectiveness. , To assess the effectiveness of the peptides under these conditions, their MBIC (Minimum Biofilm Inhibitory Concentration) and MBEC (Minimum Biofilm Eradication Concentration) values were measured against P. aeruginosa (a model pathogen) biofilms using the crystal violet assay. To determine MBIC, bacterial cells were incubated with peptides at varying concentrations for 48 h, after which biofilm formation was assessed using crystal violet staining. For MBEC evaluation, preformed biofilms (48 h) were treated with peptides at different concentrations, crystal violet staining was performed, and optical density was measured following 24 h of incubation. All peptides demonstrated potent antibiofilm activity. 2BWWR-7dL expressed MBIC and MBEC values of 7.5 μM. The modified peptides exhibited improved antibiofilm efficacy compared to the template peptide; C2–7dL displayed MBIC and MBEC values of 3 μM and 5 μM, respectively, while C3–7dL, C4–7dL, C5–7dL, and C6–7dL each showed MBIC and MBEC values of 5 μM (Figures c, S24–25). Notably, all the AMPs achieved >95% inhibition and eradication of P. aeruginosa biofilms. In summary, the antimicrobial activity of the designed peptides against several tested ESKAPE pathogens and the antibiofilm activity against P. aeruginosa were improved compared with the template peptide 2BWWR-7dL. This was most probably due to the increased positive charge density and lower hydrophobicity of the designed peptides. The increased charge density of the designed peptides led to stronger electrostatic interactions with the negatively charged microbial membranes, leading to better performance. Time-Kill Kinetics To evaluate the time taken by the peptides to eliminate bacterial cells, a time-kill kinetic assay was conducted. P. aeruginosa (105 CFU/mL) was treated with the CAMPs at their respective MIC values. At specific time intervals (0–120 min), aliquots were collected, plated on agar plates, and colony counts were determined after 24 h of incubation. The results indicated that all designed peptides eliminated bacterial cells more rapidly than the standard antibiotic polymyxin B. Peptides 2BWWR-7dL, C2–7dL, C4–7dL, C5–7dL, and C6–7dL achieved complete killing within 10 min of incubation. C3–7dL demonstrated even faster activity, eliminating cells within 5 min. In contrast, polymyxin B required more than 120 min to achieve complete bacterial killing (Figures d, S26). In one of our previous studies, polymyxin B was shown to take nearly 24 h to eliminate the bacterial population. Hemolytic Activities of Peptides For any therapeutic, it is mandatory to have noncytotoxicity against mammalian cells. Hence, the primary motive of this particular study was to reduce the mammalian toxicity of the template peptide 2BWWR-7dL by manipulating the hydrophobicity–hydrophilicity balance of the designed peptides. The hemolytic activity of the peptides was evaluated using human red blood cells (RBCs) (Figures a, S27). The template peptide 2BWWR-7dL exhibited high hemolytic activity with an HC50 of 10 μM and had a low therapeutic index of 1.23. The therapeutic index (TI) is an indicator of the selectivity of antimicrobials toward microbial cells over mammalian cells, and a high value of TI indicates a potent and safe antimicrobial therapeutic. The incorporation of ω-amino acid residues in derivatives C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL led to a marked reduction in hemolytic activity, with HC50 values of ∼1 mM, 1 mM, 0.5 mM, 0.4 mM, and 0.2 mM, respectively. This resulted in significantly enhanced TI of 176.2, 193.7, 86, 61.5, and 22.8, respectively. Notably, all the designed peptides exhibited substantial improvements in TI compared to the parent peptide 2BWWR-7dL (Figure c). Among the designed peptides, C3–7dL demonstrated the highest TI (∼194) and the greatest (157-fold) improvement in TI compared to the template peptide. This striking improvement can be attributed to a perfectly optimized hydrophobic–hydrophilic balance in this peptide. It is also worth noting that the hemolytic activity was reduced to the greatest extent in C2–7dL and C3–7dL, but showed a gradual increase within the series from C4–7dL to C6–7dL. This could be due to an increase in the carbon chain length of the N-terminal ω- amino acid residues, leading to a simultaneous increase in hydrophobicity and a decrease in charge density. A) graph depicting hemolytic activity of peptides against 10% human RBC at various concentrations (2 μM-10 mM) of peptide 2BWWR-7dL, C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL. Untreated cells were used as a negative control, while Triton-X 100-treated cells were used as a positive control and used for normalization. b) MTT assay showing cytotoxicity of peptides against adult human dermal fibroblast cells (AHDF). The cells were incubated with increasing concentrations of peptides (1.25 μM- 320 μM), and cell viability (%) was calculated. Untreated cells were used as a control. c) therapeutic indices (TI) of the peptides as calculated using MIC90 and HC50. The parent peptide, 2BWWR-7dL, contained hydrophobic leucine residues, enabling efficient partitioning into RBC lipid bilayers due to its amphipathicity and dimeric nature, leading to pronounced hemolysis. Retaining the overall charge while introducing short, nonpolar chains at the N-terminus (β-Ala-OH or GABA–OH) lowered the overall hydrophobicity relative to 2BWWR-7dL, as supported by retention time data. This modification weakened peptide–RBC membrane interactions by reducing the required hydrophobic interactions and favored interfacial retention over deep membrane insertion, thereby reducing toxicity. In contrast, extending the nonpolar chain length in C4–7dL, C5–7dL, and C6–7dL (5-Ava–OH, ε-Acp–OH, and 7-Ahp–OH) enhanced the hydrophobicity, facilitating deeper insertion into the hydrophobic core of the bilayer and resulting in the gradual regain of hemolytic activity. Cytotoxicity of Peptides The cytotoxicity of the peptides toward the adult human dermal fibroblast (AHDF) cell line was assessed using the MTT assay. The findings were consistent with the hemolysis results, indicating that the modified peptides C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL exhibited higher cell survival rates compared to those of the template peptide 2BWWR-7dL (Figure b). Moreover, the peptides maintained complete cell viability at their biologically active concentrations, highlighting their potential for therapeutic applications. Proteolytic Stability of Peptides HPLC and MALDI Analysis Proteolytic stability is another crucial property that determines the suitability of peptides as therapeutic agents. For effective action in the human body, peptides must resist degradation by the various proteases present in biological systems. To investigate this, the peptides were incubated with an enzyme cocktail (1:1:1 trypsin:chymotrypsin:proteinase K), and the chemical integrity of the peptide was analyzed using analytical HPLC and MALDI-MS. The peptide samples were analyzed at different time intervals (0, 1, 3, 6, and 12 h). The corresponding chromatographic profiles and the percentage of intact peptide after 12 h are presented in Figures a, S28, and Table S1. Peptides 2BWWR-7dL, C2–7dL, and C3–7dL showed almost complete protease stability, with 90%, 88%, and 87% intact peptide, respectively, even after 12 h of incubation. The observation was corroborated by MALDI analysis (Figure S29). In contrast, C4–7dL, C5–7dL, and C6–7dL began to degrade after 3 h, with only 40%, 29%, and 26% of the intact peptide left, respectively. In the present study, all the peptides contained the same branched core sequence, (llwwrrl)2K-CONH2, but differed in the N-terminal ω-amino acid residue. The peptides containing smaller residues with 2 and 3 carbons (β-ala and GABA) showed much higher stability, retaining almost 96% integrity after 1 h and 90% after 12 h. This suggested that the shorter residues provided limited hydrophobic surface and did not promote productive binding to proteinase K. In addition, the compact nature of these amino acids reduced the conformational freedom and kept susceptible peptide bonds less exposed to the enzyme. Whereas the peptides containing longer spacers with 4, 5, and 6 carbons (5-Ava, ε-Acp, and 7-Ahp) retained almost 85% integrity after 1 h and decreased to 30% after 12 h. This could be due to the longer and more flexible hydrophobic chains, which enhanced nonspecific hydrophobic interactions with proteinase K and improved substrate presentation to the active site. Although the peptide backbone was mostly composed of D-amino acids, the longer ω-amino acid residues increased the conformational freedom and presented the peptide backbone in a manner that was more permissive to enzyme approach, thereby facilitating cleavage at accessible sites within the branched scaffold, especially during prolonged incubation. Thus, the observed difference in stability reflected a balance between the protective effect of D-residues and the opposing effect of the hydrophobic N-terminal ω- amino acid residues. The longer residues appeared to partially overcome stereochemical resistance by increasing local hydrophobic engagement and substrate accessibility. Graphs depicting the percentage of intact peptides after: a) treatment of 2BWWR-7dL, C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL with an enzyme cocktail (1:1:1 of trypsin, chymotrypsin, and proteinase K) for different time intervals (1, 3, 6, and 12 h) b) treatment of 2BWWR-7dL and C3–7dL with 25% human serum; c) Minimum inhibitory concentration determination of the peptides after incubation with protease and serum for 1 h against P. aeruginosa using a micro broth dilution assay; d) development of drug resistance in P. aeruginosa after continuous exposure to sub-MIC concentrations of 2BWWR-7dL, C3–7dL, and polymyxin B for 45 days. Activity After Protease Treatment The antimicrobial activity of the peptides in the presence of an enzyme cocktail (trypsin: chymotrypsin: proteinase K) was assessed using a microbroth dilution assay against a model organism, P. aeruginosa. The peptides were incubated with the enzyme cocktail for 1 h, and the activity was checked. The peptides 2BWWR-7dL, C2–7dL, and C3–7dL showed no change in their MIC values of 7.5, 3, and 3 μM, respectively. Whereas C4–7dL, C5–7dL, and C6–7dL showed a partial loss in activity (Figures c, S32a). The results were consistent with the analytical HPLC and MALDI analysis of the protease-treated peptides. Since C3–7dL demonstrated superior protease stability relative to the other analogues and retained strong overall antimicrobial activity, its serum stability was studied. Serum Stability of Peptides HPLC and MALDI Analysis Human serum contains a variety of proteases that can compromise the chemical integrity of peptides. In addition, nonspecific interactions with serum proteins can lead to a loss of activity. Any therapeutic targeted for systemic delivery has to encounter the serum, and thus, a good therapeutic must be serum-stable. The stability of peptides 2BWWR-7dL and C3–7dL was evaluated in the presence of human serum by using analytical HPLC and MALDI. The peptides were incubated in 25% serum for 12 h; thereafter, their chemical integrity was analyzed by HPLC. Both C3–7dL and the template peptide 2BWWR-7dL remained ∼90% intact (Figures b, S30, Table S2). Their high serum stability was attributed to the constituent D-amino acids. This observation was further supported by MALDI analysis, which confirmed the stability of the peptides under these conditions (Figure S31). Activity After Serum Treatment The activity of the peptides 2BWWR-7dL and C3–7dL against P. aeruginosa was evaluated after serum treatment using the microbroth dilution assay. Both 2BWWR-7dL and C3–7dL maintained their activity in the presence of serum, with MIC values of 7.5 μM and 3 μM, respectively (Figures c, S32b). Identification of the Lead Peptide C3–7dL was identified as the best among the library of peptides generated due to its high antimicrobial potency in the absence/presence of salts against a broad range of ESKAPE pathogens, effective antibiofilm activity, fast manifestation of bactericidal activities, nonhemolytic and noncytotoxic attributes toward mammalian cells, and high protease/serum stability. We have performed in-depth investigations to probe the reason behind the striking improvement in the therapeutic index (TI) of C3–7dL over the template peptide 2BWWR-7dL, hereafter. Resistance Development Antimicrobial resistance has become a major challenge in modern medicine, as many pathogens are increasingly developing resistance to conventional antibiotics, posing a serious threat to effective treatment. To evaluate whether the peptides 2BWWR-7dL and C3–7dL could prevent the development of resistance, the bacterial Gram-negative pathogen (P. aeruginosa) was continuously exposed to the peptides and the antibiotics (polymyxin B) for 45 days. The MIC was measured at five-day intervals. The results showed that both peptides, 2BWWR-7dL and C3–7dL, maintained a constant MIC of 7.5 μM and 3 μM against P. aeruginosa throughout the 45-day exposure period. In contrast, polymyxin B exhibited a gradual increase in MIC after 10 days (Figure d). This established that P. aeruginosa developed resistance specifically toward the conventional antibiotic polymyxin B, over the developed CAMPs. This emergence of resistance is attributed to differences in the mechanisms of action between antibiotics and peptides. The primary target of the antibiotic polymyxin B is lipid A within the lipopolysaccharide (LPS) layer of the outer membrane of P. aeruginosa. Modifications of lipid A mediated by the PhoPQ/PmrAB regulatory systems reduce the net negative charge of LPS, thereby weakening electrostatic interactions with polymyxins. In contrast, CAMPs such as 2BWWR-7dL and C3–7dL interact through electrostatic interactions with the negatively charged LPS as well as phospholipids present in the bacterial membranes. This involves a broad range of targets on the bacterial membrane, which makes it difficult for bacteria to introduce extensive modifications without compromising membrane integrity. Consequently, the development of resistance against these CAMPs is minimal and occurs at a much slower rate. Peptide-Membrane Interaction The initial interaction between the peptide and membranes is primarily driven by electrostatic attraction between the positively charged residues of the peptide and the negatively charged bacterial membrane constituting of LPS components in Gram-negative bacteria and LTA components in Gram-positive bacteria. These anionic sites are normally cross-linked by divalent cations such as Mg2+ and Ca2+, which stabilize the membrane and keep it tightly ordered and impermeable. The peptide’s positive charges form ionic pairs with the phosphates, teichoic acids, and acidic sugar groups, effectively neutralizing surface charge and displacing Mg2+ /Ca2+ bridges between neighboring LPS/LTA moieties. , Once the peptide is electrostatically anchored to the membrane, hydrophobic interactions become increasingly important. The peptide backbone inserts into the bilayer lipid membrane and eventually causes membrane rupture. Optimum hydrophobic–hydrophilic balance is thus of utmost importance for high activity and selectivity. We investigated how this balance was important in improving the activity and selectivity of our designed peptides over the template CAMP through various experiments discussed below, using the Gram-negative pathogen P. aeruginosa as the model. Blue Shift of Fluorescence Emission Maxima (λmax) in the Presence of Bacterial/Mammalian Membrane Mimics 2BWWR-7dL and its analogues contained tryptophan, which could be used to study peptide-membrane interactions. Due to its borderline hydrophobicity, the tryptophan residue is known to be embedded at the membrane interface upon membrane binding. , Any change in the emission maxima of the tryptophan residue indicates a change in its microenvironment due to membrane binding. To understand their membrane binding, fluorescence studies of peptides were performed in the presence of membrane-mimicking systems. Negatively charged sodium dodecyl sulfate (SDS) micelles were employed as a bacterial membrane model, and zwitterionic dodecylphosphocholine (DPC) micelles served as a mammalian membrane mimic. The peptides were incubated with SDS (10 mM) and DPC (2 mM) micelles at their respective MICs. All the peptides exhibited a pronounced blue shift in the presence of SDS micelles. 2BWWR-7dL, C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL had shift values of 14, 16, 15, 14, 12, and 15 nm, respectively, indicating strong peptide-membrane mimic interactions. The trend in the λmax blueshifts was consistent with their antimicrobial activity against bacterial cells (Figure a). In contrast, with DPC, peptide 2BWWR-7dL displayed a greater blue shift (6 nm) compared to its analogs, suggesting a higher tendency to interact with mammalian membrane mimics. The modified analogs, however, showed reduced blue shifts relative to the parent peptide (∼0–2 nm), indicating diminished interaction with mammalian membranes. Notably, peptides C3–7dL and C4–7dL demonstrated a complete absence of blue shift, suggesting a lack of interaction with DPC. This aligned with the hemolysis study, where these peptides exhibited minimal hemolytic activity compared to the others. a) Blueshift in the intrinsic tryptophan fluorescence of the peptides 2BWWR-7dL, C2–7dL, C3–7dL, C4–7dL, C5–7dL, and C6–7dL. Changes in λmax of all the peptides upon interaction with SDS (bacterial membrane mimic) and DPC (mammalian membrane mimic). Solvent accessibility of peptides in the presence of acrylamide as the quencher with: b) SDS, c) DPC. d) enhancement in fluorescence of NPN dye upon incubation of the peptides with P. aeruginosa cells (outer membrane permeability). e) enhancement in fluorescence of PI dye upon incubation of the peptides with P. aeruginosa cells (inner membrane permeability). f) carboxyfluorescein dye leakage assay from LUVs (POPG:POPC) (1:1) in the presence of the peptides. Triton X was used as the positive control. g) LPS binding assay demonstrating the ability of peptides to interact with LPS from P. aeruginosa in the presence of bacterial cells. h) fluorescence spectra showing enhanced fluorescence of DiSC3(5) upon incubation of peptides with P. aeruginosa cells. Solvent Accessibility of Trp in the Presence of Membrane Mimics The selectivity of the peptides toward bacterial and mammalian membrane mimics was evaluated using a solvent accessibility assay. Peptides, at their MIC concentrations, were incubated with membrane mimetics SDS and DPC at their respective critical micellar concentrations (CMC). The samples were then exposed to increasing concentrations of acrylamide, a fluorescence quencher. The differential interactions of the peptides with SDS and DPC were illustrated in Figure b and c. Lower Stern–Volmer constant (Ksv) values of the peptides in the presence of SDS micelles, compared to DPC micelles, indicated stronger interactions with bacterial membrane mimics over mammalian membrane mimics. Furthermore, analysis of the peptide–DPC plots revealed a clear trend in slope variation. The template peptide exhibited relatively lower Ksv values with DPC than the analog peptides, indicating a higher tendency to interact with mammalian membrane mimics than the modified peptides. Among the derivatives, C3–7dL showed the highest Ksv values, reflecting the least interaction with DPC micelles. These findings were consistent with the hemolysis and cytotoxicity data. Outer Membrane Permeability (NPN Uptake Assay) The capacity of the peptides to disrupt the outer membrane of P. aeruginosa was evaluated by using an NPN uptake assay. NPN is a hydrophobic probe that exhibits minimal fluorescence in aqueous environments (outside the cell) but shows a strong increase in fluorescence upon partitioning into hydrophobic environments, such as lipid bilayers. When the outer membrane is compromised, structural defects expose the phospholipid regions or hydrophobic domains. This allows NPN to access these sites, resulting in a proportional increase in fluorescence intensity. The peptides were mixed with the NPN-incubated bacterial cells, and the change in fluorescence was studied for 20 min. Triton X was used as the positive control. Figure d indicates that, among all the peptides, C3–7dL produced the highest fluorescence increase, corresponding to nearly 55% NPN uptake. This was followed by C4–7dL, C5–7dL, C2–7dL, 2BWWR-7dL, and C6–7dL, which exhibited approximately 53%, 50%, 45%, 42%, and 38% uptake, respectively (Figure d). The outer membrane permeability diminished with increasing hydrophobicity or diminishing positive-charge density. This could be attributed to the negatively charged LPS-mediated binding of the outer membrane. Inner Membrane Permeability (PI Uptake Assay) The tendency of the peptides to permeabilize the inner membrane of Gram-negative bacteria, P. aeruginosa, was assessed using a PI uptake assay. Propidium iodide (PI) is a cell-impermeable dye that can only enter lysed or damaged cells and shows fluorescence when binding with the DNA of the cell. The peptides, at their MIC concentrations, were mixed with the PI-incubated cells at 105 CFU/mL, and the change in PI fluorescence was observed for 20 min. Figure e shows that C2–7dL, C3–7dL, C4–7dL, C5–7dL, C6–7dL, and 2BWWR-7dL showed an increasing PI uptake, with almost 49%, 57%, 65%, 66%, 67%, and 73% increments in fluorescence, respectively. Once across the outer membrane, the peptide needs sufficient hydrophobicity to be inserted into the phospholipid bilayer. Low hydrophobicity yields poor partitioning, which is insufficient for inner membrane disruption. Hence, inner-membrane permeability increased with increasing hydrophobicity in the analog library. Carboxyfluorescein Leakage from POPG:POPC LUVs A carboxyfluorescein dye leakage assay was conducted to investigate the effect of the peptides on negatively charged microbial membranes. Carboxyfluorescein-encapsulated LUVs composed of POPG:POPC (1:1) were used as a model anionic bacterial membrane mimic. Peptides at their MIC concentrations were incubated with the dye-loaded LUVs, and the increase in fluorescence was monitored over 15 min. Released carboxyfluorescein exhibits higher fluorescence compared to its self-quenched state within the vesicles. Triton X served as the positive control. The peptides induced an increase in fluorescence, following the order: C2–7dL, C3–7dL, C4–7dL, C5–7dL, C6–7dL, and 2BWWR-7dL, with approximately 54%, 58%, 63%, 70%, 76%, and 81% leakage, respectively (Figure f). The observed dye leakage trend was consistent with PI permeation into the membrane, as both processes reflected the peptide’s ability to permeate the inner membrane. These findings suggested that increased hydrophobicity enhanced the ability of the peptides to insert into and disrupt the inner membranes of Gram-negative bacteria. LPS Binding Assay As discussed earlier, the outer membrane of Gram-negative bacteria is asymmetric, with the outer leaflet enriched in lipopolysaccharides (LPS) that form a hydrophilic glycan layer. CAMPs initially associate with negatively charged LPS through electrostatic interactions, followed by insertion into the membrane, leading to outer membrane permeabilization. Thus, LPS binding represents a critical initial step. To evaluate the LPS-binding ability of the peptides, an assay was performed in which peptides at their MIC concentrations were mixed with increasing concentrations of LPS and then incubated with bacterial cells. The results showed that the bactericidal activity of C3–7dL decreased significantly even at a low LPS concentration (0.01 mg/mL), indicating strong LPS binding. In comparison, C2–7dL, C4–7dL, and C5–7dL exhibited reduced activity at moderately higher LPS concentrations (∼0.04 mg/mL). C6–7dL and 2BWWR-7dL showed a decline in bactericidal activity only at higher LPS concentrations of 0.08 mg/mL and 0.16 mg/mL, respectively (Figure g). These observations suggest that C3–7dL has the strongest LPS-binding affinity among all the peptides. This trend is consistent with the NPN uptake assay, as enhanced LPS binding correlates with greater outer membrane destabilization and permeabilization, consequently leading to higher NPN uptake. Thus, peptides with the highest positive charge density and least hydrophobicity led to the strongest outer membrane binding, which is affected through LPS binding. Membrane Depolarization Assay In the presence of strong LPS-binding peptides, divalent cations such as Mg2+ and Ca2+ that stabilize the LPS, are displaced, resulting in destabilization of the outer membrane. This disruption generates defects in the outer membrane that increase the exposure of the periplasmic space and inner membrane, leading to leakage of periplasmic ions. The resulting ion imbalance causes a collapse of the membrane potential, a process termed membrane depolarization. To evaluate the effect of the peptides on membrane potential, a depolarization assay was performed using the voltage-sensitive dye DiSC3(5), which exhibits increased fluorescence upon membrane depolarization. , Dye-incubated bacterial cells were treated with peptides at their respective MICs, and fluorescence changes were monitored over 20 min. The results showed that the extent of fluorescence enhancement followed the order: C3–7dL > C4–7dL > C5–7dL > C2–7dL > 2BWWR-7dL > C6–7dL (Figure h). These findings are consistent with the trends observed in the NPN uptake and LPS binding assays. Collectively, the results indicate that C3–7dL exhibits the strongest LPS-binding ability, leading to the most effective outer membrane permeabilization and membrane depolarization. This behavior was driven by the strongest positive charge density and the least hydrophobicity of C3–7dL. Thermodynamics of Peptide-Membrane Mimic Interaction: Isothermal Titration Calorimetry The thermodynamics of membrane interactions for the template peptide 2BWWR-7dL and the lead peptide C3–7dL were investigated using isothermal titration calorimetry (ITC) with SDS micelles as a bacterial membrane mimic and DPC micelles as a mammalian membrane mimic (Figure ). In these experiments, the peptides were titrated against small volumes of SDS and DPC, and the resulting interaction curves were analyzed using a one-site binding model. The dissociation constants (K d) obtained from the isotherms showed that 2BWWR-7dL and C3–7dL exhibited K d values of 186 μM and 465 μM, respectively, toward SDS micelles. In contrast, significantly weaker binding was observed with DPC micelles, where the K d values were 7.25 × 106 μM for 2BWWR-7dL and 9.26 × 106 μM for C3–7dL. These findings indicate that both peptides interact more favorably with SDS than with DPC, suggesting a stronger preference for bacterial membrane mimics over mammalian membrane mimics. Furthermore, analysis of the peptide–DPC isotherms revealed that 2BWWR-7dL displayed marginally stronger binding to DPC than C3–7dL, indicating the improved selectivity of C3–7dL toward bacterial membrane mimics. This trend in selectivity is consistent with observations from previous experiments. Isothermal Titration Calorimetry (ITC). Determination of binding abilities of 2BWWR-7dL against: (a) SDS, (b) DPC, and C3–7dL against: (c) SDS, (d) DPC. FESEM Imaging of Peptide-Treated Bacterial Cells FESEM imaging was used to visualize the morphological impact of the peptides (template peptide 2BWWR-7dL and lead peptide C3–7dL) on the P. aeruginosa membrane. Peptide (2BWWR-7dL and C3–7dL)-treated bacterial samples were fixed with glutaraldehyde before microscopic analysis. Untreated cells exhibited an intact morphology with well-preserved membranes, indicating healthy, undamaged cells (Figure a). In contrast, cells exposed to 2BWWR-7dL (Figure b) and C3–7dL (Figure c) showed clear signs of membrane disruption and structural damage. The leakage of intracellular contents was evident, which ultimately led to cell lysis and death. Similarly, cells treated with polymyxin B displayed compromised membranes and a loss of intracellular material (Figure d). Overall, the FESEM observations supported a membranolytic mechanism of action for the peptides. FESEM images showing morphological changes in P. aeruginosa cells in: a) healthy cells, and in the presence of b) 2BWWR-7dL, and c) C3–7dL. d) polymyxin B-treated bacterial cells were used as the control. Discussion In an attempt to improve the hemolytic activity of the template cationic AMP 2BWWR-7dL, while retaining/improving its microbial efficacy, we manipulated its hydrophobic–hydrophilic balance, a feature crucial for membrane binding. We modified the analogs through the addition of ω-amino acid residues at the N-termini of the template peptide. Peptides C2–7dL to C6–7dL contained ω-amino acid residues -NH-(CH2)n-CO-, where n = 2–6. With the charge of the peptides remaining constant, the addition of ω-amino acid residues of different lengths at the N-termini altered the hydrophobic–hydrophilic balance of the designed peptides. Introduction of a β-Ala residue at the N-terminus of 2BWWR-7dL decreased the hydrophobicity of C2–7dL due to an increase in the charge density. However, lengthening the backbone of the ω- amino acids systematically decreased the charge density and increased the hydrophobicity of the peptides, with C6–7dL having similar hydrophobicity to the template peptide. Antimicrobial studies against a range of pathogenic strains revealed that the designed peptides exhibited greater activity than the template, with C3–7dL being the most potent. C3–7dL exhibited salt tolerance, the fastest killing, and the best stability among all analogs and the template peptide. It retained the lack of resistance development in pathogens like the template peptide. All the designed peptides had improved antibiofilm potential compared to the template and were successful in almost completely (>95%) inhibiting and eradicating biofilms at very low concentrations (5 μM). All the designed peptides showed a stark improvement in hemolytic behavior over the template peptide. C3–7dL exhibited a high therapeutic index (∼194), with a 157-fold increase over the template peptide, making it a hemolytically safe therapeutic. All the peptides were completely noncytotoxic toward mammalian cells at their biologically relevant concentrations. The cytotoxicity of the analog peptides was improved over that of the template peptide. However, the therapeutic index against mammalian cells was less striking than that against RBCs. This was due to the difference in the cell membranes of the two cell types. The clear improvement in the selectivity of the designed peptides over the template was due to the refinement of the hydrophobic–hydrophilic balance. The best activity of C3–7dL was due to the optimum hydrophobic–hydrophilic balance attained in it. We further investigated to understand how the hydrophobic–hydrophilic balance determined and controlled the activity and selectivity of the CAMPs in general, and our lead peptide C3–7dL in particular. The initial interaction of the CAMPs with the microbial membrane involves an electrostatic interaction between the peptides and the membrane. This occurs through the interaction with the lipopolysaccharide (LPS) and teichoic acid present in the outer membrane of Gram-negative and Gram-positive bacteria, respectively. We established that the LPS-binding ability of the CAMPs, their outer membrane permeabilization ability, and membrane depolarization ability were directly proportional to the positive charge density of the CAMPs. We also proved that the inner membrane permeability and the leakage of dye from LUVs (a model of intracellular leakage) were favored with increasing hydrophobicity. This understanding clearly explains why a balanced proportion of both high charge density (hydrophilicity) and hydrophobicity is essential for effective antimicrobials. Also, from the tryptophan fluorescence blueshift and quenching studies and ITC experiments, it was clear that high positive charge density and hydrophobicity led to a loss of CAMP selectivity, leading to their indiscriminate binding to bacterial and mammalian membranes (as in the template peptide 2BWWR-7dL), making them cytotoxic. Thus, even for attaining high selectivity, the right balance of hydrophobicity–hydrophilicity was essential. The best antimicrobial potency of C3–7dL among all the analogues suggested that this peptide had the best trade-off between hydrophobicity and hydrophilicity, enabling efficient LPS (outer membrane) binding, disruption of membrane potential, permeation of both the outer and inner membranes, intracellular leakage, and membranolysis. The striking improvement in the therapeutic index of C3–7dL was also an outcome of its optimum hydrophobic–hydrophilic balance, making it an effective and biosafe CAMP. Conclusion In this study, we have effectively improved the selectivity of the branched CAMPs by refining their hydrophobic–hydrophilic balance through the introduction of ω- amino acid residues at their N-termini. ω-Amino acids served a 2-fold purpose: modification of the hydrophobic–hydrophilic balance and promotion of protease/serum stability. C3–7dL emerged as the best potential therapeutic, with high broad-spectrum activity, salt tolerance, antibiofilm abilities (complete inhibition and eradication), high selectivity and biosafety, protease/serum stability, and absence of resistance development in the model organism P. aeruginosa. Moreover, in this study, we mechanistically established why the optimum hydrophobic–hydrophilic balance is essential for the high activity and selectivity of CAMPs. Such an in-depth mechanistic understanding will enable the development of effective, stable, and biosafe antimicrobials in the future. Methods and Experiments General Materials The Fmoc-protected amino acids, Rink amide resin, and coupling agents (HoBT and HBTU) were obtained from GL Biochem (Shanghai, China). DIPEA was purchased from Spectrochem Pvt. Ltd., Mumbai, India. DCM and HPLC-grade ACN were purchased from Finar Limited, Ahmedabad, India. DMF, piperidine, pyridine, diethyl ether, TFA, TIS, NaH2PO4, Na2HPO4, NaCl, KCl, and KH2PO4 were purchased from Merck Life Science Pvt. Ltd., Mumbai, India. Nutrient broth, BHI broth, chymotrypsin, and proteinase K were purchased from Himedia Laboratories Pvt. Ltd., Mumbai, India. DPC, POPG, and POPC were purchased from Avanti Polar Lipids, Inc., USA. SDS, NPN, PI, acrylamide, glutaraldehyde, D2O, Triton X-100, and trypsin were purchased from Sigma-Aldrich, St. Louis, MO, USA. Bacterial Strains and Mammalian Cell Culture Common laboratory strains of E. coli (MTCC 433), P. aeruginosa (MTCC 2488), S. aureus (MTCC 96), and K. pneumoniae (MTCC 432) were obtained from the Microbial Type Culture Collection and Gene Bank (MTCC), Chandigarh, India. MRSA was S. aureus MRSA 100 (clinical strain isolated from AIIMS, New Delhi), kindly provided by Prof. Aiyagari Ramesh, IIT Guwahati. VRSA cells were developed in our laboratory using S. aureus (MTCC 96). The AHDF cell line was procured from the ATCC. Peptide Synthesis and Purification All the peptides were synthesized using the Fmoc-based solid-phase peptide synthesis method on MBHA-Rink amide resin (loading 0.7 mmol/g). For the first coupling of Fmoc-Lys­(Fmoc)–OH, 3 equiv of Fmoc-protected amino acid, 3 equiv of coupling reagent (HOBT, HBTU), and 3 equiv of base (DIPEA) were used. For further coupling of the branched chain, the coupling amounts were doubled. Coupling cycles were followed by capping for 30 min with a 7:2:1 ratio mixture of DMF: acetic anhydride: pyridine. Subsequently, Fmoc deprotection was done using 20% piperidine in DMF. The synthesized peptide was then cleaved from the resin using a cleaving cocktail of TFA (96% TFA, 2.5% TIS, 1.5% H2O) for 1.5 h. The peptide was precipitated in cold diethyl ether, followed by centrifugation to obtain the crude solid peptide. The obtained crude peptides were purified using reverse-phase HPLC (Thermo Scientific Dionex Ultimate 3000) on a semipreparative Biobasic 8 column using a binary ACN-H2O (5–100%) solvent system at a flow rate of 10 mL/min using dual UV detection at 214 nm (amide bond) and 280 nm (tryptophan). The purity of the peptides was checked on a Thermo Scientific Dionex Ultimate 3000 analytical HPLC system using a linear gradient of 5–100% ACN-H2O and a flow rate of 1 mL/min. Purified peptides were characterized using MALDI-MS (TOF) and 600 MHz 1H NMR. All the peptides were >95% pure. CD Analysis Secondary structures of the peptides in water were determined using CD spectroscopy. CD spectra of 50 μM peptide solutions in water were recorded. The spectra were acquired by pipetting each of the solutions in a 300 μL Hemla quartz cuvette of 1 mm path length. A wavelength range of 190–260 nm, a scanning rate of 100 nm/min, a data pitch of 1 nm, a response time of 4 s, and a bandwidth of 1 s were used. Spectra were acquired using a JASCO J-1500 CD spectrometer. Zeta Potential Analysis The zeta potential of the peptides was obtained at 298 K using a 632.8 nm He–Ne laser with a Zetasizer Nano-ZS90 (Malvern) instrument. A 50 μM solution of peptides was made in phosphate buffer (pH 7.4, 10 mM), and the measurements were done in triplicates. Broth Microdilution Assay The antimicrobial activity of the peptides was studied using a standard broth microdilution assay. MIC determination was done against Gram-negative strains P. aeruginosa, E. coli, and K. pneumoniae, and Gram-positive strains S. aureus, methicillin-resistant S. aureus, and vancomycin-resistant S. aureus. Gram-negative strains and Gram-positive strains were cultured in NB media and BHI media, respectively, at 37 °C. The mid-log phase of the bacterial strains, obtained from an overnight-grown culture, was centrifuged (6000 g) for 6 min and washed thrice in 10 mM (pH 7.4) phosphate buffer alone and in the presence of 150 mM NaCl. Subsequently, the cells were resuspended and diluted to 106 CFU/mL in the same buffer. To examine the minimum inhibitory concentration (MIC) of peptides with and without salt, 50 μL of cells (106 CFU/mL) were incubated at 37 °C in a 96-well plate with varying peptide concentrations (1 μM to 200 μM) so that the final concentration of cell was 105 CFU/mL, for 4 h. Untreated cells were used as the negative control whereas polymyxin B- and vancomycin-treated cells were used as the positive controls for Gram-negative and Gram-positive strains, respectively. After 4 h of incubation, 100 μL of the respective media was added to each well, and the plates were incubated again overnight at 37 °C with constant shaking (180 rpm). The absorbance was monitored by optical density measurement at 630 nm using a Multiskan GO spectrophotometer (Thermo Scientific). The results were plotted as % growth of cells as a function of peptide concentrations. The positive controls were used to normalize all the readings. The minimum peptide concentration at which 90% bacterial growth was inhibited was considered the minimum inhibitory concentration (MIC90) of the peptide. All experiments were repeated at least twice and performed in triplicate. Hemolytic Activity The hemolytic activities of the peptides were tested against human erythrocyte cells using a previously standardized protocol. Fresh human blood was collected from a healthy voluntary donor. The collected blood was left to clot for 30 min to separate serum/plasma from RBCs. One milliliter of the collected RBCs was centrifuged at 3000 g for 10 min, washed thrice in PBS buffer (pH 7.4, 10 mM), and resuspended in the same buffer. Peptide solutions at different concentrations (2 μM–10 mM) were incubated with 10% RBCs for 1 h at 37 °C with continuous shaking. Untreated and 1% Triton X-100-treated RBCs were used as negative and positive controls, respectively. The incubated samples were centrifuged for 10 min at 4 °C at 8000 g. The % heme release was quantified by monitoring the absorbance of the supernatant solution on an OD plate reader at 540 nm. Heme release in the Triton X-treated RBCs was considered 100% and was used to normalize all the readings. The digital images of the samples were also taken. All the experiments were done in triplicate. The color of the supernatant showed the extent of cell lysis by the AMP. The therapeutic index (TI) of the peptides was calculated by the given formula TherapeuticIndex=HC50/MICgm Cytotoxicity Assay (MTT Assay) Cytotoxicity of synthesized peptides was assessed using the MTT assay on adult human dermal fibroblasts (AHDF). AHDF cells were seeded in 96-well plates at 2000 cells/well and maintained in Dulbecco’s Modified Eagle Medium (DMEM, Gibco, Cat. no. 11995–065) supplemented with 10% fetal bovine serum (FBS, Gibco, Cat. no. A5256701) and 1% penicillin-streptomycin in a 37 °C incubator with 5% CO2. After 24 h, the culture medium was replaced with fresh medium containing the peptides at concentrations ranging from 1.25 to 320 μM. The peptide solutions were prepared by serial two-fold dilution of a 320 μM stock solution in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. Untreated cells (0 μM peptide) served as the control. Cells were incubated with peptides for 24 h, after which the medium was replaced with DMEM basal medium containing 0.25 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma, Cat. no. 475989). Plates were incubated at 37 °C for 2 h, after which the MTT medium was aspirated and formazan crystals were solubilized by adding 100 μL dimethyl sulfoxide (DMSO, HiMedia, Cat. no. MB058) per well with thorough mixing. Absorbance was measured at 570 nm, with a 650 nm reference used for background correction, using a microplate reader. Percent cell viability was calculated for each peptide concentration relative to untreated controls (0 μM peptide, normalized to 100%). IC50 values, representing the concentration causing 50% growth inhibition, were determined by nonlinear regression analysis. The assay was performed in three biological replicates, each with technical triplicates. Time-Killing Kinetics The overnight-grown mid-log phase P. aeruginosa cells were collected by centrifugation at 6000 g for 6 min, washed thrice in phosphate buffer (pH 7.4, 10 mM), and resuspended in the same buffer to a concentration of 106 CFU/mL. A 50 μL aliquot of bacterial cells (final concentration of cells was 105 CFU/mL) was incubated with 1 × MIC of peptides and the control, polymyxin B, at 37 °C for different intervals of time until 2 h. After each incubation time, 10 μL was spread onto NB agar plates and incubated overnight at 37 °C. Subsequently, colony counting was done, and digital images were taken. Drug Resistance Assay The resistance development was evaluated by serial passaging of P. aeruginosa over 45 consecutive passages. At the start of the experiment, the MICs of 2BWWR-7dL, C3–7dL, and polymyxin B (positive control) were determined using the previously described broth microdilution method. An inoculum size of 1 × 105 CFU/mL was used for each passage. Following overnight incubation at 37 °C, bacteria from the highest peptide concentration that permitted visible growth (i.e., a sub-MIC well) were collected, diluted to 1 × 105 CFU/mL, and used to inoculate newly prepared serial dilutions of the respective peptides or polymyxin B. MICs were reassessed every fifth passage, while the serial passaging was continued daily for a total of 45 passages. Resistance emergence was defined as a ≥4-fold increase in the MIC after 45 passages relative to the initial MIC determined at passage 0. Biofilm Inhibition Assay The overnight-grown mid-log phase P. aeruginosa cells were incubated in nutrient broth in a sterile 96-well microtiter plate in the presence of varying concentrations of peptides (1–100 μM) for 48 h in a static and humid condition at 37 °C. Following incubation, the media were removed, and wells were washed thrice with sterile water (100 μL) to remove any nonadherent bacterial cells. The wells were air-dried, and a 0.1% (w/v) crystal violet solution (150 μL) was added to each well and incubated for 30 min to stain the biofilm. The crystal violet stain incorporated by the biofilms was solubilized with 95% ethanol (200 μL), and the biofilm biomass was estimated by transferring the ethanol-solubilized dye solution from each well into a fresh well and measuring its absorbance at 590 nm in a microtiter plate reader. Biofilm growth in the absence of peptide and in the presence of polymyxin B was treated as negative and positive controls, respectively. % Biofilm growth was calculated for each well and plotted as a function of peptide concentration. All experiments were repeated twice and performed in triplicate. Biofilm Eradication Assay The overnight-grown mid-log phase P. aeruginosa cells were incubated in nutrient broth in a sterile 96-well microtiter plate and left to grow for 48 h in static and humid conditions at 37 °C. Following incubation, the media were removed, and the wells were washed thrice with sterile water (100 μL) to remove nonadherent bacterial cells. The mature biofilms were incubated with 100 μL of varying concentrations of peptides (1–100 μM) in media for 24 h. The treated biofilms were then washed thrice with sterile water and air-dried. 0.1% (w/v) crystal violet solution (150 μL) was added to each well and incubated for 30 min to stain the biofilm. The crystal violet stain incorporated by the biofilms was solubilized with 95% ethanol (200 μL), and the biofilm biomass was estimated by transferring the ethanol-solubilized dye solution from each well into a fresh well and measuring the absorbance at 590 nm in a microtiter plate reader. Biofilm growth in the absence of peptide and in the presence of polymyxin B was treated as negative and positive controls, respectively. % Biofilm growth was calculated for each well and plotted as a function of peptide concentration (μM). All experiments were repeated twice and performed in triplicate. Protease Resistance of Peptides A) HPLC Experiment Peptides at 10 mM concentrations were incubated with a 1:1:1 mixture of the enzymes trypsin, chymotrypsin, and proteinase K at 37 °C. After incubation at different time intervals (0 h, 1 h, 3 h, 6 h, and 12 h), an aliquot of 50 μL of the reaction mixture was mixed with 50 μL of acetonitrile solution containing 1% TFA and was kept for 30 min at 4 °C to inactivate the enzymes. The solution was then diluted with HPLC-grade water (1:1), and 20 μL was injected onto the C18 reverse-phase column for analytical HPLC analysis with an increasing ACN percentage of 5–100% at a flow rate of 1 mL/min for 25 min. The percentage of intact peptides was quantified by determining the area under the enzyme-treated peptide peaks (214 nm) and comparing it with the area under the peaks for untreated peptides using Agilent Open Lab CDS software. B) Mass Spectrometry To study the effect of proteases on the chemical integrity of our peptides, we conducted mass analysis. Peptides were treated with an enzyme cocktail of trypsin, chymotrypsin, and proteinase K. Post-treatment aliquots were taken at different time intervals (0 h, 12 h) and analyzed using MALDI-MS. C) Antimicrobial Activity Post-Enzyme Treatment To verify whether the peptides maintained their antimicrobial activity after serum treatment, we utilized the broth microdilution technique, as previously outlined, to determine their minimum inhibitory concentrations (MICs) against P. aeruginosa. The enzyme-treated peptides, at different concentrations, were incubated with cells at 105 CFU/mL, and the MIC determination was done. Serum Stability of Peptides A) HPLC Experiment Human serum was extracted from fresh human blood collected from a healthy voluntary donor. The blood was left standstill for about an hour to clot. After clotting, the RBCs and serum were separated by centrifuging the blood at 2500 g for 10 min. The peptides 2BWWR-7dL and C3–7dL (10 mM) were incubated with 25% human serum at 37 °C for 4 h. After incubation at different time intervals (0 h, 1 h, 3 h, 6 h, and 12 h), an aliquot was taken, mixed with ACN:methanol:water (8:1:1), centrifuged to remove the precipitated proteins from the serum, and kept at 4 °C for 30 min to inactivate the enzymes. The solution was then diluted with HPLC-grade water (1:1), and 20 μL was injected onto the C18 reverse-phase column for analytical HPLC analysis with an increasing ACN percentage of 5–100% at a flow rate of 1 mL/min for 25 min. The percentage of intact peptides was quantified by determining the area under the serum-treated peptide peaks (214 nm) and comparing it with the area under the peaks for untreated peptides using Agilent Open Lab CDS software. B) Mass Spectrometry To study the effect of serum on the chemical integrity of the peptides, we conducted a mass analysis. Peptides were treated with 25% human serum, as discussed earlier. Post-treatment aliquots were taken at different time intervals (0 h, 12 h) and analyzed using MALDI-MS. C) Antimicrobial Activity Post-Serum Treatment To verify whether 2BWWR-7dL and C3–7dL maintained their antimicrobial activity after serum treatment, we utilized the broth microdilution technique, as previously outlined, to determine their minimum inhibitory concentrations (MICs) against P. aeruginosa. The serum-treated peptides, at different concentrations, were incubated with cells at 105 CFU/mL, and the MIC determination was done. Fluorescence Experiments Blue Shift in the Presence of Membrane Mimetics The intrinsic tryptophan fluorescence of the peptides was utilized to check the interaction of peptides with membrane mimics. All of the peptides, at their respective MICs against P. aeruginosa, were treated with SDS (bacterial cell membrane mimic) and DPC (mammalian cell membrane mimic) at their respective critical micelle concentrations (CMCs). Using the HORIBA JOBIN YVON Fluoromax-4 spectrophotometer, the tryptophan fluorescence emission (300–450 nm range) was monitored at an excitation wavelength of 280 nm and a 10 nm slit width to detect any potential blue shift. Solvent Accessibility A fluorescence quenching experiment was conducted to determine the solvent accessibility of the peptides in the presence of the membrane mimics SDS and DPC. Acrylamide, used as a static quencher, was added in small portions to a peptide-SDS complex, a peptide-DPC complex, and also to an isolated peptide, to a final concentration of 0.2 M. The resulting change in the fluorescence intensity was determined by fitting it to the Stern–Volmer equation F0/F1=1+Ksv[Q] . Here, F0 is the initial fluorescence, F1 is the fluorescence after quencher addition, [Q] is the quencher concentration, and Ksv is the Stern–Volmer constant (M–1). Outer Membrane Permeabilization Assay The overnight-grown mid-log phase P. aeruginosa cells were collected by centrifugation at 6000 g for 6 min, washed thrice in 10 mM (pH 7.4) phosphate buffer, and resuspended in the same buffer to a concentration of 105 CFU/mL. NPN dye, at a final concentration of 10 μM, was added to a 1 mL suspension of cells and incubated for 30 min under shaking conditions. The fluorescence emission of the dye was recorded for 1200 s at 298 K, with an excitation wavelength of 350 nm (slit width of 5 nm) and an emission wavelength of 410 nm (slit width of 5 nm) using the HORIBA JOBIN YVON Fluoromax-4 spectrophotometer. The fluorescence intensity of free cells was monitored for 20 min to check for any fluctuation in the intensity and to test the stability of the cells. After a stable intensity was obtained, peptides at their respective MIC were added to the NPN incubated cells. The increase in the fluorescence of the dye indicated permeabilization of the outer membrane. Inner Membrane Permeabilization Assay The overnight-grown mid-log phase P. aeruginosa cells were collected by centrifugation at 6000 g for 6 min, washed thrice in 10 mM (pH 7.4) phosphate buffer, and resuspended in the same buffer to a concentration of 105 CFU/mL. Ten micromolar propidium iodide (PI) dye was introduced into 1 mL of the cell suspension and then incubated at room temperature for 30 min under shaking conditions. The fluorescence emission of the dye was recorded for 1200 s at a temperature of 298 K, with an excitation wavelength of 535 nm (slit width of 10 nm) and an emission wavelength of 617 nm (slit width of 10 nm) using the HORIBA JOBIN YVON Fluoromax-4 spectrophotometer. The fluorescence intensity of free cells was monitored for 20 min to check for any fluctuation in the intensity to test the stability of the cells. After a stable intensity was obtained, peptides at their respective MIC were added to PI-incubated cells. The increase in the fluorescence of the dye indicated permeabilization of the inner membrane. Preparation of Carboxyfluorescein-Loaded LUVs/Release of Carboxyfluorescein Dye from the POPC/POPG LUVs Large unilamellar vesicles (LUVs) were prepared by freeze-thawing and extrusion through polycarbonate filters with a pore diameter of 100 nm in an extrusion device. Briefly, a 90 mM carboxyfluorescein solution in Tris-HCl 20 mM, NaCl 150 mM, and EDTA 1 mM buffer (pH 7.4, adjusted with NaOH 1 M) was made. A 10 mg/mL lipid (POPC/POPG 1:1 mol ratio) solution in chloroform was dried under a stream of argon, followed by 4 h of high-vacuum drying. The lipid film was rehydrated with the carboxyfluorescein solution in buffer, freeze–thawed for five cycles, and extruded 11 times. The free carboxyfluorescein was removed by passing the suspension through a Sephadex G-100 column. The release of the dye after peptide exposure was measured using a HORIBA JOBIN YVON Fluoromax-4 spectrophotometer at excitation and emission wavelengths of 480 and 510 nm, respectively. The fluorescence intensity was continuously recorded after the peptide solution at MIC was added to a 1 mL cuvette containing the carboxyfluorescein-loaded LUVs. Leakage is expressed as a percentage relative to the total amount of dye released by the addition of 1% Triton X-100, which represented 100% leakage. LPS Competitive Inhibition Assay Peptides were combined with LPS at various concentrations and incubated for 1 h. After that, P. aeruginosa cells at 105 CFU/mL were added, and the mixture was further incubated for 24 h. The measurement of the sample’s absorbance at 420 nm using a microplate reader was utilized to determine the bacterial death rate. Membrane Depolarization Assay The overnight-grown mid-log phase of P. aeruginosa cells was collected by centrifugation (6000 g), washed thrice in 10 mM (pH 7.4) phosphate buffer, and resuspended to a concentration of 106 CFU/mL. One milliliter of the bacterial cells was then incubated with DiSC3(5) (2 μM). The fluorescence of the suspension was monitored at room temperature for 20 min at an excitation wavelength of 622 nm and an emission wavelength of 670 nm. After achieving a stable intensity, peptides at their respective MIC were added to the dye-incubated cells. The fluorescence was read continuously for 20 min. Untreated cells were used as the negative control. Isothermal Titration Calorimetry Interactions of the peptides 2BWWR-7dL and C3–7dL with bacterial membrane mimic SDS and mammalian membrane mimic DPC were studied using Isothermal Titration Calorimetry. 280 μL of the peptide at a concentration of 0.25 mM was placed in the cell and titrated against an SDS solution of 10 mM concentration, with 2 μL of SDS being injected each time for 20 consecutive times. The stirring speed was maintained at 350 rpm, and the temperature was fixed at 37 °C. Isotherms for the peptides titrated against SDS were fitted using a one-binding-site model. Similarly, 0.25 mM of the peptide placed in the cell was titrated against DPC of 2 mM concentration 20 consecutive times, each injection being of 2 μL volume. The isotherms for the reactions involving peptides vs DPC were fitted using a one-binding-site model. Field Emission Scanning Electron Microscopy The overnight-grown mid-log phase of P. aeruginosa cells was collected by centrifugation at 6000 g for 6 min, washed thrice in 10 mM (pH 7.4) phosphate buffer, and resuspended in the same buffer to a concentration of 105 CFU/mL. The cells were incubated with peptides 2BWWR-7dL and C3–7dL at their respective MICs for 2 h at 37 °C. Untreated cells and polymyxin-treated cells were treated as negative and positive controls, respectively. Post-incubation the cell pellets were fixed with 2.5% glutaraldehyde for 15 min. The pellets were then washed thrice with sterile water, drop-cast on clean silicon wafers, and left to dry. The dried silicon wafers were taken for FESEM analysis. Supplementary Material